MedTrace Logo

Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.

NCT05732337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-09-08

No results posted yet for this study

Summary

The primary endpoint is the change of the itching score after 3 days of the product use in comparison to the basal value.

Conditions

  • Chickenpox

Interventions

DEVICE

Poxclin Coolmousse

cooling mousse for application in the skin

Sponsors & Collaborators

  • Karo Pharma AB

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Months
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2023-07-05
Completion
2023-07-05

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05732337 on ClinicalTrials.gov